THERALINK TECHNOLOGIES, INC. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2010 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Theralink Technologies, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2010 to Q4 2023.
  • Theralink Technologies, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending December 31, 2023 was 6.15B shares, unchanged year-over-year.
  • Theralink Technologies, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 6.15B shares, a 4.6% increase from 2022.
  • Theralink Technologies, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 5.88B shares.
  • Theralink Technologies, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2019 was 495K shares, a 30.2% decline from 2018.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 6.15B +73 0% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-20
Q2 2023 21.1B +15.1B +249% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q4 2022 6.15B Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-20
Q2 2022 6.06B Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q2 2020 388K +220K +130% Apr 1, 2020 Jun 30, 2020 10-Q 2021-06-11
Q1 2020 885K +508K +135% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-15
Q4 2019 495K -214K -30.2% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-25
Q3 2019 427K +99K +30.2% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-19
Q2 2019 168K -229M -99.9% Apr 1, 2019 Jun 30, 2019 10-Q 2021-06-11
Q1 2019 377K -500M -99.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 709K -128M -99.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-25
Q3 2018 328K -140M -99.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 230M +96.7M +72.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-15
Q1 2018 500M +421M +528% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 129M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 140M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 133M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 79.6M Jan 1, 2017 Mar 31, 2017 10-Q 2018-06-19
Q3 2014 62.9M +375K +0.6% Jun 1, 2014 Aug 31, 2014 10-Q 2014-10-14
Q2 2014 62.9M +375K +0.6% Mar 1, 2014 May 31, 2014 10-Q 2014-07-21
Q1 2014 62.6M +97.1K +0.16% Dec 1, 2013 Feb 28, 2014 10-K 2014-06-13
Q4 2013 62.5M +20.6K +0.03% Sep 1, 2013 Nov 30, 2013 10-Q 2014-01-14
Q3 2013 62.5M 0 0% Jun 1, 2013 Aug 31, 2013 10-Q 2014-10-14
Q2 2013 62.5M +41.7M +200% Mar 1, 2013 May 31, 2013 10-Q 2014-07-21
Q1 2013 62.5M +41.7M +200% Dec 1, 2012 Feb 28, 2013 10-K 2014-06-13
Q4 2012 62.5M +41.7M +200% Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-14
Q3 2012 62.5M +41.7M +200% Jun 1, 2012 Aug 31, 2012 10-Q 2013-10-17
Q2 2012 20.8M 0 0% Mar 1, 2012 May 31, 2012 10-Q 2013-07-31
Q1 2012 20.8M Dec 1, 2011 Feb 29, 2012 10-K 2013-06-28
Q4 2011 20.8M -1.67M -7.43% Sep 1, 2011 Nov 30, 2011 10-Q 2013-01-22
Q3 2011 20.8M -1.95M -8.57% Jun 1, 2011 Aug 31, 2011 10-Q 2012-10-15
Q2 2011 20.8M Mar 1, 2011 May 31, 2011 10-Q 2012-07-13
Q4 2010 22.5M Sep 1, 2010 Nov 30, 2010 10-Q 2012-01-17
Q3 2010 22.8M Jun 1, 2010 Aug 31, 2010 10-Q 2011-10-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.